Karachi September 17 2022: GlaxoSmithKline Pakistan Limited’s paracetamol brand, Calpol, is sufficiently available in the market, in both, liquids as well as tablets form for children and adults claimed by the company.
“For us, delivering to our patients is our utmost priority, and being a patient-focused company, we ensure that there is no shortage of our key brands in the market.” Says Company’s Chief Executive Officer Ms. Erum Shakir Rahim
GlaxoSmithKline reiterate that on 01 April 2016 as a result of demerger, there have been two GlaxoSmithliine legal entities registered in Pakistan; GlaxoSmithldine Consumer Healthcare and GlaxoSmithKline Pakistan Limited since 2016.
GlaxoSmithKline Consumer Healthcare is the owner of Panadol amongst other products while GlaxoSmithKline Pakistan Limited, is the owner of various pharmaceutical brands including Calpol.
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
